Search Orphan Drug Designations and Approvals
-
Generic Name: | N-(bromoacetyl)-3,3-dinitroazetidine |
---|---|
Date Designated: | 01/16/2019 |
Orphan Designation: | Treatment of glioblastoma multiforme |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
EpicentRx Inc. 11099 North Torrey Pines Road, Suite 160 La Jolla San Diego, California 92037 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-